Literature DB >> 19112067

Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease.

R S Desikan1, H J Cabral, B Fischl, C R G Guttmann, D Blacker, B T Hyman, M S Albert, R J Killiany.   

Abstract

BACKGROUND AND
PURPOSE: Mild cognitive impairment (MCI) represents a transitional state between normal aging and Alzheimer disease (AD). Our goal was to determine if specific temporoparietal regions can predict the time to progress from MCI to AD.
MATERIALS AND METHODS: MR images from 129 individuals with MCI were analyzed to identify the volume of 14 neocortical and 2 non-neocortical brain regions, comprising the temporal and parietal lobes. In addition, 3 neuropsychological test scores were included to determine whether they would provide independent information. After a mean follow-up time of 5 years, 44 of these individuals had progressed to a diagnosis of AD.
RESULTS: Cox proportional hazards models demonstrated significant effects for 6 MR imaging regions with the greatest differences being the following: the entorhinal cortex (hazard ratio [HR] = 0.54, P < .001), inferior parietal lobule (hazard ratio [HR] = 0.64, P < .005), and middle temporal gyrus (HR = 0.64, P < .004), indicating decreased risk with larger volumes. A multivariable model showed that a combination of the entorhinal cortex (HR = 0.60, P < .001) and the inferior parietal lobule (HR = 0.62, P < .01) was the best predictor of time to progress to AD. A multivariable model reiterated the importance of including both MR imaging and neuropsychological variables in the final model.
CONCLUSIONS: These findings reaffirm the importance of the entorhinal cortex and present evidence for the importance of the inferior parietal lobule as a predictor of time to progress from MCI to AD. The inclusion of neuropsychological performance in the final model continues to highlight the importance of using these measures in a complementary fashion.

Entities:  

Mesh:

Year:  2008        PMID: 19112067      PMCID: PMC2656417          DOI: 10.3174/ajnr.A1397

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  49 in total

1.  Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease.

Authors:  A Convit; J de Asis; M J de Leon; C Y Tarshish; S De Santi; H Rusinek
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  High-resolution intersubject averaging and a coordinate system for the cortical surface.

Authors:  B Fischl; M I Sereno; R B Tootell; A M Dale
Journal:  Hum Brain Mapp       Date:  1999       Impact factor: 5.038

3.  Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment.

Authors:  J H Kordower; Y Chu; G T Stebbins; S T DeKosky; E J Cochran; D Bennett; E J Mufson
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

4.  Inferior parietal lobule projections to the presubiculum and neighboring ventromedial temporal cortical areas.

Authors:  S L Ding; G Van Hoesen; K S Rockland
Journal:  J Comp Neurol       Date:  2000-10-02       Impact factor: 3.215

Review 5.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

6.  Preclinical prediction of AD using neuropsychological tests.

Authors:  M S Albert; M B Moss; R Tanzi; K Jones
Journal:  J Int Neuropsychol Soc       Date:  2001-07       Impact factor: 2.892

7.  Measuring the thickness of the human cerebral cortex from magnetic resonance images.

Authors:  B Fischl; A M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

8.  Predicting conversion to Alzheimer disease using standardized clinical information.

Authors:  E Daly; D Zaitchik; M Copeland; J Schmahmann; J Gunther; M Albert
Journal:  Arch Neurol       Date:  2000-05

9.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.

Authors:  G M McKhann; M S Albert; M Grossman; B Miller; D Dickson; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-11

10.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease.

Authors:  R J Killiany; T Gomez-Isla; M Moss; R Kikinis; T Sandor; F Jolesz; R Tanzi; K Jones; B T Hyman; M S Albert
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

View more
  41 in total

Review 1.  Quantitative structural MRI for early detection of Alzheimer's disease.

Authors:  Linda K McEvoy; James B Brewer
Journal:  Expert Rev Neurother       Date:  2010-11       Impact factor: 4.618

2.  Automated MR morphometry to predict Alzheimer's disease in mild cognitive impairment.

Authors:  Klaus H Fritzsche; Bram Stieltjes; Sarah Schlindwein; Thomas van Bruggen; Marco Essig; Hans-Peter Meinzer
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-05-04       Impact factor: 2.924

3.  MR imaging of brain volumes: evaluation of a fully automatic software.

Authors:  K Ambarki; A Wåhlin; R Birgander; A Eklund; J Malm
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

4.  Differentiating Between Healthy Control Participants and Those with Mild Cognitive Impairment Using Volumetric MRI Data.

Authors:  Renée DeVivo; Lauren Zajac; Asim Mian; Anna Cervantes-Arslanian; Eric Steinberg; Michael L Alosco; Jesse Mez; Robert Stern; Ronald Killany
Journal:  J Int Neuropsychol Soc       Date:  2019-05-27       Impact factor: 2.892

5.  Impact of the Baltimore Experience Corps Trial on cortical and hippocampal volumes.

Authors:  Michelle C Carlson; Julie H Kuo; Yi-Fang Chuang; Vijay R Varma; Greg Harris; Marilyn S Albert; Kirk I Erickson; Arthur F Kramer; Jeanine M Parisi; Qian-Li Xue; Eriwn J Tan; Elizabeth K Tanner; Alden L Gross; Teresa E Seeman; Tara L Gruenewald; Sylvia McGill; George W Rebok; Linda P Fried
Journal:  Alzheimers Dement       Date:  2015-03-31       Impact factor: 21.566

6.  Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment.

Authors:  Daniel Varon; David A Loewenstein; Elizabeth Potter; Maria T Greig; Joscelyn Agron; Qian Shen; Weizhao Zhao; Maria Celeste Ramirez; Isael Santos; Warren Barker; Huntington Potter; Ranjan Duara
Journal:  Dement Geriatr Cogn Disord       Date:  2011-04-13       Impact factor: 2.959

7.  Evaluation of automatic measurement of the intracranial volume based on quantitative MR imaging.

Authors:  K Ambarki; T Lindqvist; A Wåhlin; E Petterson; M J B Warntjes; R Birgander; J Malm; A Eklund
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-03       Impact factor: 3.825

Review 8.  Medial temporal cortices in ex vivo magnetic resonance imaging.

Authors:  Jean C Augustinack; André J W van der Kouwe; Bruce Fischl
Journal:  J Comp Neurol       Date:  2013-12-15       Impact factor: 3.215

9.  Discriminating Alzheimer's disease progression using a new hippocampal marker from T1-weighted MRI: The local surface roughness.

Authors:  Carlos Platero; María Eugenia López; María Del Carmen Tobar; Miguel Yus; Fernando Maestu
Journal:  Hum Brain Mapp       Date:  2018-11-19       Impact factor: 5.038

10.  Genetic variation of oxidative phosphorylation genes in stroke and Alzheimer's disease.

Authors:  Alessandro Biffi; Mert R Sabuncu; Rahul S Desikan; Nick Schmansky; David H Salat; Jonathan Rosand; Christopher D Anderson
Journal:  Neurobiol Aging       Date:  2014-02-05       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.